Brief: Mereo Biopharma Group PLC Says It Continues To Seek A Partner For Further Development Of Etigilimab

Mereo BioPharma

23/10/2023 21:14

Oct 23 (Reuters) - Mereo Biopharma Group PLC  MAH0y.F :
    * MEREO BIOPHARMA REPORTS ON RECENT PROGRAM DEVELOPMENTS AND
PROVIDES FINANCIAL UPDATE
    * MEREO BIOPHARMA GROUP PLC - PHASE 3 PORTION OF STUDY IS
CURRENTLY ENROLLING APPROXIMATELY 195 PATIENTS AT 50 SITES
ACROSS 12 COUNTRIES
    * MEREO BIOPHARMA GROUP PLC: CONTINUES TO SEEK A PARTNER FOR
FURTHER DEVELOPMENT OF ETIGILIMAB
    * MEREO BIOPHARMA GROUP PLC: AS OF SEPT 30, CO HAD CASH AND
SHORT-TERM DEPOSITS OF £51.2 MILLION
    * MEREO BIOPHARMA SEES EXISTING CASH, SHORT-TERM DEPOSITS TO
FUND
COMMITTED CLINICAL TRIALS, OPERATING EXPENSES, CAPEX
REQUIREMENTS INTO 2026

Source text for Eikon:  ID:nGNX2xFWMj 
Further company coverage:  MAH0y.F 

 ((reuters.briefs@thomsonreuters.com;))